Tokyo, June 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061901) titled 'Beyond Adherence: Safety Culture, Collective Awareness, and Psychological Harm in Oral Anticancer Therapy: An integrative review' on June 15.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Kindai University

Condition: Condition - cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To synthesize evidence on team-based oral anticancer treatment approaches based on a safety culture to clarify mechanisms affecting the quality of broad treatment implementation, including psychological distress, adherence rates, safety, and quality of life in organizational structures and team processes Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1) Studies involved adult patients receiving oral chemotherapy either on an outpatient or home basis. 2) Research related to team-based care models and organizational or interdisciplinary interventions that consider safety and culture in the provision of oral therapy . 3) Research based on one of the above methods: quantitative, qualitative, mixed methods, implementation research, or quality improvement design. 4) Targeting at peer-reviewed papers or authoritative reports that provide sufficient methodological detail for evaluation and extraction. Key exclusion criteria - 1) Studies are excluded if they did not involve an oral anticancer therapy context, including infusion-only regimens without an oral component. 2) Studies are excluded if they focusing exclusively on pharmacologic efficacy without consideration of care processes, team functioning, or system-level factors. 3) Reports unrelated to safety culture or team-based care, and that do not address implementation outcomes related to psychological or compliance, are excluded

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 12 Month 15 Day Date of IRB - 2025 Year 12 Month 15 Day Anticipated trial start date - 2026 Year 01 Month 01 Day Last follow-up date - 2026 Year 09 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070828

Disclaimer: Curated by HT Syndication.